Cargando…
180. Duration of Therapy and Clinical Outcomes in Adult Oncology Patients with Uncomplicated Coagulase Negative Staphylococcal Bacteremia
BACKGROUND: Although they are often considered contaminants, coagulase negative staphylococci (CoNS) can be pathogens especially in immunocompromised patients. National and local guidelines recommend treatment durations of 7 to 14 days, depending on specific clinical scenarios. The objective was to...
Autores principales: | Fairbanks, Amanda, Li, Jessica, Sweet, Ania, Tverdek, Frank, Liu, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644075/ http://dx.doi.org/10.1093/ofid/ofab466.382 |
Ejemplares similares
-
Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates
por: van der Lugt, N Margreth, et al.
Publicado: (2010) -
Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital
por: Yamada, Koichi, et al.
Publicado: (2017) -
684. Diagnostic Yield of Echocardiography in Coagulase Negative Staphylococcus Bacteremia
por: Nagarakanti, Sandhya, et al.
Publicado: (2021) -
ICU stay promotes enrichment and dissemination of multi-resistant coagulase-negative staphylococcal clones
por: Agvald-Ohman, C, et al.
Publicado: (2005) -
Incidence of coagulase-negative staphylococcal bacteremia among ICU patients: decontamination studies as a natural experiment
por: Hurley, James C
Publicado: (2019)